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Abstract
We present a case of adenomyoepithlioma (AME) arising from the tonsil. AME is an uncommon tumor that typi-
cally arises in breast, but rarely found in salivary glands, lung, and skin. Its biological features have not been thor-
oughly characterized. Here we describe a primary AME originating from the tonsil. The pathologic changes were
characterized by hypercellularity, the dominance of both epithelial and myoepithelial cells. Malignancy was evi-
denced by the presence of a high mitotic rate and invasive growth. The epithelial cells express high levels of cyto-
keratin and epithelial membrane antigen (EMA). The myoepithelial cells show positive staining for calponin, p63,
vimentin, and S-100. A thorough review of the literature indicates that this is likely the first reported case of AME
from the tonsil. Following descriptions of the diagnosis, treatment, and prognosis of this specific case, pathologic
and clinical characteristics of AME from other tissues are also compiled and discussed.
Introduction
Adenomyoepitheliomas (AME) were first described as a
rare primary breast tumor by Hamperl in 1970, and
fully documented by Kiaer and Eusebi in the mid 1980s.
While most adenomyoepithelioma cases were observed
in breast, rare cases were found in salivary gland, skin,
and lung. Adenomyoepithelioma arising from the tonsil
has not been documented in previous literature.
Adenomyoepitheliomas, also known as Epithelial-
myoepithelial carcinomas, are considered to be low-
grade, malignant neoplasms consisting of a dual popula-
tion of cells, epithelial cells and myoepithelial cells.
These two cells types form bilayered glandular struc-
tures, the inner layer of epithelial-type cells and the
outer layer of myoepithelial-type cells [1]. The patholo-
gical lesion is caused mainly by the deregulated, anaplas-
tic proliferation of epithelial and myoepithelial cells. In
this report, we describe an adenomyoepithelioma origi-
nating in the tonsil of an elderly woman. We describe
the findings from histopathologic studies using multiple
diagnostic markers, as well as treatment procedures and
differential diagnosis of this particular lesion. Features of
adenomyoepitheliomas arising from breast, salivary
gland, lung, and skin are also discussed.
Case report
Clinical reviews
The patient was a 63-year-old female with an unremark-
able medical history for both herself and her family. Her
chief complaint was the discomfort in her pharynx and
larynx, which had been gradually aggravated for the last
3 months. A fragile, tan neoplasm was found at
the lower surface of the left tonsil with the size of 1.0 ×
1.0 cm. The neoplasm seemed to bleed easily with
touch. No ulceration or mucosal erosion was noted.
Hyperplasia of lymphatic tissue was observed in the
posterior wall of the pharynx. Biopsy was performed and
the histological examination revealed a tumor composed
of epithelial and myoepithelial cells. Tonsillectomy was
implemented for the left side under local anesthesia.
The patient has no history of known malignant disease,
and no neoplasm was identified by full-body imaging
studies.
Pathological and immunohistochemical findings
The gross appearance of the tumor was a 1.0 × 1.0 cm
sized, lobulated neoplasm with an off-white coarser sur-
face. A vertical section of the tumor showed red to gray
color. Histologically, the tumor showed bicellular prolif-
eration of both epithelial cells and myoepithelial cells
(Fig 1a). Fig 1b shows that the tumor cells invaded into
the surrounding tissues, indicating a pattern for invasive
growth. Tumor cells are tightly packed, often organized
in “glandular” structures (Fig 1C). In addition, Fig 1d
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mitotic events. Both epithelial cells and myoepithelial
cells show pleomorphic cytomplasm and nuclei charac-
teristic of atypia. Atypical cells are enlarged in size, con-
tain irregular nuclei with one or two prominent
nucleoli, or show condensed nuclei with dark staining.
In the high-power fields, the glandular structure (Fig 1e)
and presence of clear cells (Fig 1f) are better observed.
Immunohistochemical staining of Fig 2 show the char-
acter of biphasic epithelial and myoepithelial cells. EMA
and CK are representative markers for epithelial cells.
This case is consistent with the presence of such. The
glandular epithelial cells positively react to both epithe-
lial membrane antigen (EMA) and cytokeratin (CK) (Fig
2a, b), but were negative for S100 protein, a-smooth
muscle actin (SMA), and vimentin (negative staining
was not shown). In Fig 2a (EMA staining), the positive
staining was only found in gland duct epithelial cells,
but not in myoepithelial cells. Cytokeratin is usually
expressed mostly in glandular epithelial cells, but
occasionally the protein is also expressed in myoepithe-
lial cells. This is seen in our case; CK is most strongly
positive in gland duct epithelial cells, but is also positive
in myoepithelial cells (Fig 2b showed). In Fig 2c, d, e, f,
g, the myoepithelial cells were respectively strongly posi-
tive for vimentin, S100 protein, P63 and calponin.
Vimentin, SMA and Calponin were seen positive in the
cytoplasm of myoepithelial cells in Fig 2c, d and 2g,
respectively. Fig 2e shows S-100 highly expressed in
both the cytoplasm and nuclei of myoepithelial cells;
while P63 was observed positive in the nuclei of myoe-
pithelial cells. Ki-67 labeling was positive and the PCNA
positive rate was > 90% (not shown). SMA, calponin,
and S-100 are characteristic markers of myoepithelial
cells. In our case, myoepithelial cells match this charac-
teristic immunhistochemical feature. The characteristic
diagnostic molecules for epithelial cells include EMA
and CK, while the representative molecules for myoe-
pithelial cells are SMA, calponin, and S-100. In our
case, both myoepithelial cells and epithelial cells express
Figure 1 HE staining (a), the tumor surface is covered with squamous epithelium cells (40×); (b), tumor cells invaded to the surrounding
connective tissues (100×); (c), the structure of the tumor(100×); (d), mitotic phase of the tumor (200×); (e), the structure of the glands (200×); (f),
clear cells in the tumor (200×).
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myoepithelial cells highly express Vimentin, SMA, S100,
P63, Calponin, Ki-67 and PCNA. The epithelial cells
highly express EMA and cytokeratin, while reacting
negatively to S100, SMA and Vimentin. This expression
pattern is consistent with the major diagnostic features
of adenomyoepithelioma.
Treatment and prognosis
Given a malignant neoplasm of the tonsil, tonsillectomy
was always the first choice of treatment. After the sur-
gery, the pathological diagnosis of adenomyoepithelioma
was confirmed based on both light microscope evalua-
tion (routine HE staining) and immunohistochemical
analysis using specific antibodies. The patient received a
chemotherapy regimen of: Epirubicin 60 mg daily 1 +
Cis-platinum 50 mg daily 1~2 + Calcium folinate 200
mg daily 1~5 + Tegafur 800 mg daily 1~5, for 4 cycles.
During the chemotherapy, the side effects of digestive
system complications (grade I) and marrow suppression
(grade II) were observed. After the 4 cycles of systemic
chemotherapy, a CT scan of the head and neck showed
a slightly thicker oropharyngeal wall than the normal
tissue. Multiple enlarged cervical lymph nodes in the
carotid triangle were found. Local radiation therapy was
subsequently prescribed and the patient received three-
dimensional-conformal radiation-therapy. The target
region included the tumor bed and regional lymph
Figure 2 Immunohistochemical staining, Brown particle was regarded as positive staining signal. (a), Immunostaining of EMA (200×),
EMA antibody was from MaiXin and was 1:80 diluted; (b), Immunostaining of cytokeratin (200×), CK antibody was from MaiXin and was 1:60
diluted; (c), Immunostaining of Vimentin (200×), Vim antibody was from Zhong Shan and was 1:100 diluted; (d), Immunostaining of smooth
muscle actin (200×), SMA antibody was from MaiXin and was 1:60 diluted; (e), Immunostaining of S-100 (200×), S-100 antibody was from Zhong
Shan and was 1:80 diluted; (f), Immunostaining of P-63 (200×); P-63 antibody was from Zhong Shan and was 1:80 diluted; (g), Immunostaining of
Calponin (200×) Cal antibody was from MaiXin and was 1:80 diluted;
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target area, isodose curve, and the dose-volume histo-
gram are shown in Fig 3. During a 1-year follow-up per-
iod, there has been no evidence of local recurrence or
distant metastasis.
Discussion
Adenomyoepithelioma (AME) as a diagnostic term has
been applied to a broad range of biphasic lesions com-
posed of epithelial and myoepithelial cells. AME is fea-
tured as simultaneous proliferations of epithelial and
myoepithelial elements. In this case, we found the
simultaneous dominancy of epithelial and myoepithelial
cells, and both epithelial cells and myoepithelial cells
highly express their respective characteristic molecules.
The characteristic molecules of epithelial cells include
EMA and CK, while the representative markers for
myoepithelial cells are SMA, calponin, S-100, and
GFAP. The immunohistochemistry staining features dis-
tinguish this tumor from a mixed tumor and support
the diagnosis as AME.
Depending on the pathologists’ preference, other diag-
nostic terms have been used for AME of different
organs. The terms adeno-myoepithelioma, malignant
adeno-myoepithelioma, and epithelialmyoepithelial ade-
noma, and epithelial-myoepithelial carcinoma have the
same meaning. But myoepitheliaomas and their malig-
nant counterpart, myoepithelial carcinoma, are different
concepts than AME [2].
Myoepitheliomas are tumors composed predominantly
or exclusively of myoepithelial cells without ductal
(epithelial) development. They are well-described
Figure 3 Plan of Three Dimensional-Conformal Radiation-Therapy. (a, b, c): The distribution of target region, the target region includes the
primary malignancy, pharyngeal lymphoid ring and upper cervical lymph node region; (d, e, f): The distribution of isodose curve, the total tissue
dose is 70Gy/35f. The 95% isodose curve covered the planning target volume; (g), The dose-volume histogram showed that the radiation doses
received by the surrounding normal tissues, which include brain stem, spinalcord and lens, are all lower than the safe dose threshold.
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occur also in the breast and tracheobronchial tree where
myoepithelial cells are normally present. Myoepithelial
carcinoma is malignant myoepithelioma. There are no
definite histological criteria for discriminating benign
and malignant myoepitheliomas. As for myoepithelial
tumors, nuclear atypia, high mitotic rate and infiltrative
growth into adjacent tissues have been proposed as fea-
tures suggestive of malignant myoepitheliomas. Immu-
nohistochemically, tumor cells are positive for both
epithelial markers (EMA and CK) and myogenic mar-
kers (alpha-SMA and calponin), variably together with
S-100 protein and GFAP. However, it must be noted
that the tumor cells are not always positive for these
markers, and that negative staining does not necessarily
exclude myoepithelial differentiation.
Common features of adenomyoepithelioma
Ultrastructural features of AME are junctional com-
plexes and apical secretory granules in the periluminal
epithelial cells, and basal lamina and myofilaments with
focal densities in the myoepithelial cells. The tumors
demonstrating a potential for recurrence or metastasis
generally had higher mitotic rates, cellular atypia and
less well defined margins [3];
Immunohistochemistry staining of AME demonstrates
that the myoepithelial cells express S100 protein, Calpo-
nin, smooth muscle actin or/and GFAP while not react-
ing with epithelial markers. The inner epithelial
component usually reacts with cytokeratins and EMA,
but is non-reactive with S100 and smooth muscle actin.
The representative molecules of epithelial cells include
EMA and CK, while the characteristic molecules of
myoepithelial cells are SMA, calponin, S-100, and
GFAP. In our case, both myoepithelial cells and epithe-
lial cells highly express their respective characteristic
molecules.
Studies of cell proliferation of salivary AME found
that the solid tumors show an overgrowth of myoepithe-
lial-type cells, suggesting that these cells represent the
‘proliferative compartment’ of tumors. This is in accor-
dance with the observation in breast AME that cell pro-
liferation and aneuploidy are restricted to the
myoepithelial-type cell layer, which suggests that the
inner layer of epithelial cells represent a more differen-
tiated cell type, probably resulting from differentiation
of the myoepithelial type cells.
Adenomyoepitheliomas arising from different organs
Breast adenomyoepithelioma
AME found in breast are much more common than
those found in salivary glands, skin, and lung. Some
authors have questioned the name “breast adenomyoe-
pithelioma” since these tumors are often histologically
identical to and behave in the same fashion as epithelial-
myoepithelial carcinomas of salivary gland, lung, or skin.
The patient age ranges from 24 to 86 yr, with a mean
age of 57 yr [4,5]. Breast AME has been divided into
three patterns in terms of histology: spindle-cell, tubular,
and lobulated types. Gross examination usually reveals a
mass of 0.5 to 10 cm diameter with well-defined or irre-
gular borders. The texture can range from firm, elastic,
or rubbery to soft. Papillary or cystic structures may be
found in the cut surface. Foci of hemorrhage or necrosis
can also be seen, and sometimes calcifications are pre-
sent. Upon microscopic examination, the tumor can be
found to be delineated by a true or pseudo-capsule and
is composed of the epithelial and myoepithelial compo-
nent. Depending on the relative abundance of the two
different components, the growth patterns, and the cyto-
logical appearances, the tumors can have great variabil-
ity in histological presentation. The epithelial
component may form solid nests or groups, ducts, cys-
tic, rabecular, pseudo-papillary, or papillary structures.
Electron microscopy will demonstrate the biphenotypic
nature of these cells containing 6-nm actin myofila-
ments and basal lamina, along with desmosomal struc-
tures and perinuclear intermediate filament bundles.
Breast AME has a wide spectrum of cytological fea-
tures. In the majority of cases, large, tightly cohesive
aggregates with a dual population of epithelial and
myoepithelial cells were present. The common cytomor-
phologic features of breast AME include [6]: 1) cellular
smears or cohesive sheets containing epithelial and
myoepithelial cells; 2) acinar, finger-like, or papillary
p a t t e r n ;3 )a b u n d a n tb i p o l a rn a k e dn u c l e ii nt h eb a c k -
ground. There are also some uncommon features, such
as: 1) spindle cells in groups and singly; 2) atypical
epithelial cells. Immunohistochemical studies of breast
AME indicated the following features. Cytokeratins such
as CAM5.2, CK7, or AE1/3 cocktail highlight the epithe-
lial tubules, with an often more subtle staining of the
myoepitheial cells. The myoepithelial component is gly-
cogen-rich, which can be detected by periodic acid
schiff’s staining. The same type of cells also contains
actin that can be recognized by specific antibodies
immunohistochemically with S-100 and variably with
smooth muscle actin. Muscle specific actin, calponin,
and desmin usually stain the myoepithelial cells strongly.
Epithelial membrane antigen, p63, cytokeratin 14, CD10,
and even glial fibrillary acidic protein3 have also been
shown to be present in myoepithelial cells.
Although most of breast AMEs are considered benign,
they can recur locally, or progress subsequently to a
malignant state and give rise to metastases. Malignant
transformation may involve epithelial cells, myoepithelial
cells, or both cellular elements [7]. According to the
most recent World Health Organization (WHO)
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myoepithelial carcinoma arising in an AME; 2) epithelial
carcinoma arising in an AME; 3) malignant epithelial
and myoepithelial components; 4) sarcoma arising in
AME; 5) carcinosarcoma arising in AME [8].
Adenomyoepithelioma of salivary glands
AME of the salivary glands resembles AME of the breast
in their histological presentation. Both form double
layered structures, the inner layer of epithelial-type cells
and the outer layer of myoepithelial-type cells. Despite
these similarities, AMEs of salivary glands belong to a
different entity by the following consideration. First,
AME is a very distinctive and rare tumor type of salivary
glands. AMEs of salivary glands are also invariably
malignant, a stark contrast to AME of the breast. How-
ever, in both organs, the possible end-spectrum of the
disease is myoepithelial carcinoma. Second, Tavassoli
reported differences in glial fibrillary acidic protein
(GFAP) reactivity in the myoepithelial component of the
two tumors. The myoepithelial cells in salivary gland
AME sometimes stain for GFAP, whereas the myoe-
pithelial cells in breast AMEs do not.
Lung adenomyoepithelioma
Pulmonary AMEs with epithelial and myoepithelial dif-
ferentiation are rare, thought to be of bronchial minor
salivary gland origin and classified similarly to salivary
gland neoplasms [9-11]. Such tumors presented with
single or multiple pulmonary nodules. Histologically,
these tumors showed glandular structure and spindle
cell differentiation [12]. Some glands were filled with
colloid like secretion and had an inner, cuboidal epithe-
lial cell layer that stain positive for pankeratin, epithelial
membrane antigen, cytokeratins (CAM 5.2, CK7), SP-A,
and thyroid transcription factor-1(TTF-1), but negative
for high molecular weight keratin and myoepithelial
markers. There may also be glands lined by a single
layer of plump cells that were positive for surfactant
protein-A and other epithelial cell markers. The outer
layer of myoepithelial cells merge with foci of spindled
myoepithelial cells stained positive for high molecular
weight keratin, S100, smooth muscle actin, calponin,
caldesmon, and p63, but negative for desmin. In addi-
t i o n ,t h e yw e r ea l s os t r o n g l yp o s i t i v ef o rC K 7a n d
weakly positive for CAM 5.2 and TTF-1. Neuroendo-
crine markers (neuron-specific enolase, synaptophysin,
chromogranin) and thyroglobulin gave negative results.
Alveolar entrapment was excluded by histologic appear-
ance and by complete absence of elastic fibers within
the tumor. Electron microscopy confirmed pneumocytic
features in these cells and the myoepithelial nature of
the spindled cells [13].
Skin adenomyoepithelioma
Tumors of skin AME were also composed of epithelial
cells and myoepithelial cells. The myoepithelial cells
contained myofilaments with focal densities and hemi-
d e s m o s o m e s[ 1 4 , 1 5 ] .T h e yw e r el i m i t e db yaw e l l -
formed basal lamina. Immunohistochemically, the
epithelial cells exhibited strong expression of cytokeratin
(CAM5.2) and weak expression of carcinoembryonic
antigen. The myoepithelial cells showed diffuse positive
staining for smooth muscle actin and focal positive for
S100 protein.
We herein reported a very rare case of malignant
AME from tonsil. Based on the pathological characteris-
tics, we offer a diagnostic reference for classifying AMEs
from tonsil. This report also provides the treatment
options including chemotherapy and local radiation
therapy plans. Long-term clinical follow-up appears to
be necessary for better understanding of this disease.
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